Novonate
Palo Alto, US · Founded 2017 · Delaware corporation · 2 known investors
Find your way into Novonate
Sign up to see every warm intro you have to Novonate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novonate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novonate develops a medical device for securing umbilical catheters in neonatal patients, reducing the risk of catheter migration and early discontinuation while protecting the insertion site. The product is aimed at hospital nursing staff caring for newborns in neonatal care settings.
Founders & leadership
Novonate was founded in 2017 by Eric Chehab.
Investors · 2
Reported raises · per SEC filings
Form D private placements$624.7K disclosed across 1 round · 2017
▶$624.7KraisedDec 2017 · 3 investors · OtherRule 506(b)
- Radu CautisDirector
- Eric Fayez ChehabExecutive Officer, Director
- James WallDirector
- Offering amount
- $1.1M
- Amount sold
- $624.7K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $256K |
| National Science Foundation | Phase I | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Novonate do?
- Novonate develops a medical device for securing umbilical catheters in neonatal patients, reducing the risk of catheter migration and early discontinuation while protecting the insertion site. The product is aimed at hospital nursing staff caring for newborns in neonatal care settings.
- Who founded Novonate?
- Novonate was founded by Eric Chehab in 2017.
- Who are Novonate's investors?
- Novonate's investors include StartX, Medical Technology Venture Partners.
- How much funding has Novonate raised?
- Novonate has disclosed $624.7K raised across 1 round.
- Where is Novonate headquartered?
- Novonate is headquartered in Palo Alto, US.

